FDA Adverse Event Injury Summary report: N

THV 1000-23 3F AORTIC BIO 23MM

MDR report key: 8094457 · Received November 21, 2018

Report

Report Number
2025587-2018-03153
Event Type
Injury
Date Received
November 21, 2018
Date of Event
October 23, 2018
Report Date
November 21, 2018
Manufacturer
MEDTRONIC 3F THERAPEUTICS, INC.
Product Code
LWR
UDI-DI
00613994868237
PMA / PMN Number
P060025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: THE COMMON PROBABLE CAUSE FOR STENOSIS IS PANNUS. THIS FINDING IS GENERALLY CONSIDERED A PATIENT-RELATED CONDITION. WITHOUT THE RETURN OF THE PRODUCT, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 1 MONTH POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE DUE TO STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
937059 THV 1000-23 3F AORTIC BIO 23MM HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC 3F THERAPEUTICS, INC. 1000-23 00613994868237

Patients

Seq Age Sex Outcome Treatment
1 81 YR Required Intervention